SCHEMBL5720804

SCHEMBL5720804

CCCOC(=O)CC(N)c1cccc(Cl)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 2/20 0.44
NFKB1 P19838 2/20 0.44
PNMT P11086 1/20 0.44
ALDH1A1 P00352 4/20 0.43
LMNA P02545 3/20 0.43
GLA P06280 1/20 0.43
MAPK1 P28482 1/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
CASP1 P29466 1/20 0.39
MAPT P10636 2/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
NLRP3 Q96P20 1/20 0.37
ABCB11 O95342 2/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2C9 P11712 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720989 0.92 CYP1A2 (0.42) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL5720970 0.89 CASP1 (0.47) CYP1A2CYP3A4ALDH1A1LMNAMAPK1
SCHEMBL13802834 0.83 CYP1A2 (0.49) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL5720829 0.81 CASP1 (0.45) CYP1A2CYP3A4ALDH1A1LMNAMAPK1
SCHEMBL5720994 0.81 MAPK1 (0.48) CYP3A4CYP2D6ALDH1A1LMNAMAPK1
SCHEMBL5720912 0.80 MAPK1 (0.47) ALDH1A1LMNAMAPK1NLRP3SMN1; SMN2
SCHEMBL5720940 0.79 ALDH1A1 (0.42) ALDH1A1LMNAMAPK1MEN1KMT2A
SCHEMBL8299927 0.79 CASP1 (0.54) CYP1A2CYP3A4ALDH1A1LMNAMEN1
SCHEMBL12498544 0.79 CASP1 (0.54) CYP1A2CYP3A4ALDH1A1LMNAMEN1
SCHEMBL29839087 0.79 CASP1 (0.54) CYP1A2CYP3A4ALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto UBE INDUSTRIES, LTD. (JP) 2006-08-10 US disclosed
EP-1621529-A1 3-AMINO-3-ARYLPROPIONIC ACID n-ALKYL ESTERS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-3-ARYLPROPIONIC ACIDS AND ESTERS OF THE ANTIPODES THERETO Ube Industries, Ltd. (JP) 2006-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto ALAD, ARSA, ALDH7A1 CYP1A2 174/4885CYP3A4 110/4885CYP2D6 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.